Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.520
-0.010 (-0.65%)
Apr 29, 2026, 10:43 AM EDT - Market open
Estrella Immunopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| Market Capitalization | 65 | 59 | 43 | 38 | 19 | - | |
| Market Cap Growth | 106.35% | 35.70% | 13.67% | 101.23% | - | - | |
| Enterprise Value | 62 | 57 | 42 | 33 | 21 | - | |
| Last Close Price | 1.53 | 1.56 | 1.20 | 1.05 | 10.84 | 10.00 | |
| PB Ratio | - | -5.68 | 302.06 | 8.94 | -2.81 | - | |
| P/TBV Ratio | - | - | 302.06 | 8.94 | - | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | - | |
| Net Debt / Equity Ratio | 0.13 | 0.13 | -6.35 | -0.97 | 0.36 | -1.03 | |
| Quick Ratio | 0.10 | 0.10 | 0.31 | 23.05 | 0.25 | 4.32 | |
| Current Ratio | 0.12 | 0.12 | 0.55 | 24.65 | 0.28 | 5.20 | |
| Return on Assets (ROA) | -258.45% | -258.45% | - | -122.12% | -174.75% | - | |
| Return on Capital Employed (ROCE) | 126.00% | 126.00% | -6154.50% | -171.10% | 165.20% | -42.40% | |
| Earnings Yield | -20.48% | -22.17% | -20.38% | -19.14% | -58.56% | - | |
| Buyback Yield / Dilution | -1.63% | -1.63% | -33.68% | -8764.81% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.